Articles

  • 1 day ago | beckershospitalreview.com | Alexandra Murphy

    Charles Kraft, R.N., a Senior Consultant at Cardinal Health, shares practical approaches for identifying efficiencies and savings opportunities in your… Roche will invest up to $550 million in its Indianapolis diagnostics site by 2030 to expand production of its continuous… The U.S. and China have agreed to temporarily de-escalate their trade conflict, moving forward with a 90-day suspension of respective…...

  • 1 day ago | beckershospitalreview.com | Alexandra Murphy

    As pharmacy deserts proliferate across the U.S., particularly in rural areas, Greenville, S.C.-based Prisma Health is utilizing the 340B program to help fill the gap.

  • 1 day ago | beckersbehavioralhealth.com | Alexandra Murphy

    Advertisement Public health and addiction experts are raising concerns over President Donald Trump’s proposed budget, warning that sweeping cuts made to treatment and prevention programs could reverse progress in addressing the opioid crisis in the U.S., The New York Times reported May 13.

  • 1 day ago | beckershospitalreview.com | Alexandra Murphy

    Peoria, Ill.-based OSF HealthCare has become the first mid-to-large integrated health system in the U.S.and the seventh health system overall, to receive the American Society of Health-System Pharmacists’ Certified Center of Excellence designation for medication-use safety and pharmacy practice. The certification recognizes high standards in pharmacy operations, including medication safety, patient care services and adherence to best practices.

  • 2 days ago | beckershospitalreview.com | Alexandra Murphy

    GSK will acquire the liver disease drug efimosfermin from Boston Pharmaceuticals in a deal worth up to $2 billion, The Wall Street Journalreported May 14. The agreement includes a $1.2 billion upfront payment along with an additional $800 million tied to future development and regulatory agreements. As part of the deal, GSK will acquire Boston Pharmaceuticals’ subsidiary BP Asset IX to gain full rights to the drug.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map